Solstein Capital’s Merck MRK Stock Holding History

Solstein Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.8K	Hold	255	–	–	0.01%	258
2026 Q1	$30.7K	Buy	+255	New	+$29.4K	0.01%	261
2025 Q3	–	Sell	-176	Closed	-$13.9K	–	492
2025 Q2	$13.9K	Buy	+176	New	+$14K	0.01%	310
2022 Q4	–	Sell	-700	Closed	-$60K	–	308
2022 Q3	$60K	Hold	700	–	–	0.05%	144
2022 Q2	$64K	Hold	700	–	–	0.05%	164
2022 Q1	$57K	Hold	700	–	–	0.04%	181
2021 Q4	$54K	Hold	700	–	–	0.03%	206
2021 Q3	$53K	Hold	700	–	–	0.03%	225
2021 Q2	$54K	Sell	700 -34	-5%	-$2.53K	0.07%	212
2021 Q1	$54K	Buy	+734	New	+$54.1K	0.07%	197
2020 Q4	–	Sell	-734	Closed	-$58K	–	161
2020 Q3	$58K	Hold	734	–	–	0.13%	123
2020 Q2	$54K	Hold	734	–	–	0.13%	108
2020 Q1	$54K	Sell	734 -2,162	-75%	-$170K	0.21%	77
2019 Q4	$251K	Buy	+2,896	New	+$238K	0.51%	46

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Solstein Capital's MRK Position: Q2 2026 in Review

Solstein Capital held its Merck (MRK) position steady in Q2 2026 at 255 shares worth $32.8K. The position accounts for 0.01% of the portfolio, ranked #258.

Solstein Capital first reported a position in MRK in Q4 2019 and has held it in 14 quarters since. The position peaked at $251K in Q4 2019. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Solstein Capital held 255 shares of Merck worth $32.8K as of Q2 2026.
Solstein Capital left its Merck share count unchanged in Q2 2026.
Merck made up 0.01% of Solstein Capital's portfolio in Q2 2026, its #258 holding.
Solstein Capital first reported a position in Merck in Q4 2019 and has held it in 14 quarters since.
Solstein Capital's Merck position peaked at $251K in Q4 2019.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.